Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua DeAguero

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 18, 2026
Gadolinium-Based Contrast Agents and the Theater of SafetyJoshua DeAguero, Brent Wagner
Frontiers in Toxicology|November 24, 2025
Editorial: Magnetic resonance imaging contrast agents: the safety of gadoliniumJohn Sy, Joshua DeAguero, Brent Wagner
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 9, 2022
Rosuvastatin-Induced Rhabdomyolysis, Pancreatitis, Transaminitis, and Acute Kidney InjuryBrent Wagner, G Patricia Escobar, D Bradley Jackson, et al.
Cell Biology and Toxicology|April 2, 2025
Early endolysosomal dysfunction is a contributing factor to gadolinium-based contrast agent mouse renal proximal tubule epithelial cell injuryJoshua DeAguero, Tamara Howard, G Patricia Escobar, et al.
Kidney360|August 23, 2021
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice EvolutionCatherine Do, Joshua DeAguero, Adrian Brearley, et al.
Frontiers in Medicine|June 1, 2022
Dysnatremia in Gastrointestinal DisordersCatherine Do, Gretta J Evans, Joshua DeAguero, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|August 8, 2022
Gadolinium Deposition Disease: A Case Report and the Prevalence of Enhanced MRI Procedures Within the Veterans Health AdministrationD Bradley Jackson, Terence MacIntyre, Vianey Duarte-Miramontes, et al.
American Journal of Physiology. Renal Physiology|February 22, 2021
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosisFrancesca Bruno, Joshua DeAguero, Catherine Do, et al.
Magnetic Resonance Imaging|March 10, 2025
Precipitation of gadolinium from magnetic resonance imaging contrast agents may be the Brass tacks of toxicityIan M Henderson, Angelica D Benevidez, Curtis D Mowry, et al.
Scientific Reports|February 4, 2023
The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposureJoshua DeAguero, Tamara Howard, Donna Kusewitt, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Journal of the American Society of Nephrology : CJASN|May 18, 2026
Gadolinium-Based Contrast Agents and the Theater of SafetyJoshua DeAguero, Brent Wagner
Frontiers in Toxicology|November 24, 2025
Editorial: Magnetic resonance imaging contrast agents: the safety of gadoliniumJohn Sy, Joshua DeAguero, Brent Wagner
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 9, 2022
Rosuvastatin-Induced Rhabdomyolysis, Pancreatitis, Transaminitis, and Acute Kidney InjuryBrent Wagner, G Patricia Escobar, D Bradley Jackson, et al.
Cell Biology and Toxicology|April 2, 2025
Early endolysosomal dysfunction is a contributing factor to gadolinium-based contrast agent mouse renal proximal tubule epithelial cell injuryJoshua DeAguero, Tamara Howard, G Patricia Escobar, et al.
Kidney360|August 23, 2021
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice EvolutionCatherine Do, Joshua DeAguero, Adrian Brearley, et al.
Frontiers in Medicine|June 1, 2022
Dysnatremia in Gastrointestinal DisordersCatherine Do, Gretta J Evans, Joshua DeAguero, et al.
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|August 8, 2022
Gadolinium Deposition Disease: A Case Report and the Prevalence of Enhanced MRI Procedures Within the Veterans Health AdministrationD Bradley Jackson, Terence MacIntyre, Vianey Duarte-Miramontes, et al.
American Journal of Physiology. Renal Physiology|February 22, 2021
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosisFrancesca Bruno, Joshua DeAguero, Catherine Do, et al.
Magnetic Resonance Imaging|March 10, 2025
Precipitation of gadolinium from magnetic resonance imaging contrast agents may be the Brass tacks of toxicityIan M Henderson, Angelica D Benevidez, Curtis D Mowry, et al.
Scientific Reports|February 4, 2023
The onset of rare earth metallosis begins with renal gadolinium-rich nanoparticles from magnetic resonance imaging contrast agent exposureJoshua DeAguero, Tamara Howard, Donna Kusewitt, et al.
Pageof 2